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Identification of PSD-95 Palmitoylating Enzymes
Scaria et al., 1994), and numerous G protein-coupledMasaki Fukata,1 Yuko Fukata,1
Hillel Adesnik,2 Roger A. Nicoll,2 receptors (Bouvier et al., 1995). Importantly, palmitoyla-
tion occurs in a reversible fashion (Milligan et al., 1995;and David S. Bredt1,*
1Department of Physiology and Mumby, 1997; Ross, 1995; Wedegaertner and Bourne,
1994), which allows palmitoylation to dynamically regu-2Department of Cellular and Molecular
Pharmacology late protein function and to participate in diverse as-
pects of neuronal signaling.University of California at San Francisco
San Francisco, California 94143 The postsynaptic density protein, PSD-95, represents
a major palmitoylated protein in brain (Topinka and
Bredt, 1998). PSD-95 is palmitoylated at cysteine resi-
dues 3 and 5 (Topinka andBredt, 1998). This lipidmodifi-Summary
cation is critical for PSD-95 clustering of AMPA recep-
tors at excitatory synapses (El-Husseini Ael et al., 2002).Palmitoylation is a lipid modification that plays a criti-
cal role in protein trafficking and function throughout Furthermore, the palmitoylation of PSD-95 is dynami-
cally regulated by synaptic activity, such that cyclingthe nervous system. Palmitoylation of PSD-95 is es-
sential for its regulation of AMPA receptors and synap- of palmitate on PSD-95 can contribute to aspects of
synaptic plasticity (El-Husseini Ael et al., 2002).tic plasticity. The enzymes that mediate palmitoyl acyl
transfer to PSD-95 have not yet been identified; how- Although protein palmitoylation was first identified
over 30 years ago, the enzymes that add palmitate toever, proteins containing a DHHC cysteine-rich do-
main mediate palmitoyl acyl transferase activity in proteins and those that cleave the thioester bond have
been elusive. Recent elegant genetic studies in yeastyeast. Here, we isolated 23mammalianDHHCproteins
and found that a subset specifically palmitoylated have identified proteins that mediate palmitoyl trans-
ferase activity (Linder and Deschenes, 2004; SmotrysPSD-95 in vitro and in vivo. These PSD-95 palmitoyl
transferases (P-PATs) showed substrate specificity, and Linder, 2004). Forward genetic screens in yeast
identified Erf2/4 (Bartels et al., 1999; Lobo et al., 2002;as they did not all enhance palmitoylation of Lck,
SNAP-25b, Gs, or H-Ras in cultured cells. Inhibition Zhao et al., 2002) and Akr1p (Roth et al., 2002) as pal-
mitoyl transferases for yeast Ras2 and yeast caseinof P-PAT activity in neurons reduced palmitoylation
and synaptic clustering of PSD-95 and diminished kinase2 (Yck2). Deletion of Erf2/4 or Akr1p prevents pal-
mitoylation of Ras2 or Yck2, respectively. Also, recombi-AMPA receptor-mediated neurotransmission. This
study suggests that P-PATs regulate synaptic function nant Erf2/4 and Akr1p palmitoylate Ras2 and Yck2
in vitro; however, these enzymes were inactive towardthrough PSD-95 palmitoylation.
mammalian proteins. Erf2 and Akr1p share a conserved
DHHC cysteine-rich domain (Linder and Deschenes,Introduction
2004; Smotrys and Linder, 2004). Our sequence analysis
indicates that 23 DHHC proteins are encoded in thePosttranslational modifications of proteins provide a
central molecular mechanism for neurons to respond to human and mouse genomes. Very recently, Keller et al.
reported that Golgi apparatus-specific protein with theexternal stimuli. The importance of protein phosphoryla-
tion cascades in controlling neuronal growth, differentia- DHHC zinc finger domain (GODZ; here called DHHC-3),
one of the mammalian DHHC proteins, enhanced palmi-tion, and plasticity is well established. Other protein
modifications, including ubiquitination, acetylation, gly- toyl transfer to GABA-A receptor 2 subunit in heterolo-
gous cells (Keller et al., 2004). However, the biologicalcosylation, and lipid modification also play crucial roles
in neuronal responses to their environment. Lipidmodifi- significance of mammalian DHHC proteins remains un-
clear.cations not only alter protein structure but also increase
the hydrophobicity of proteins, which can cause them In this study, we asked whether DHHC proteins func-
to adhere to cellular membranes (Casey, 1994; Dunphy tion generally as palmitoyl transferases in mammals and
and Linder, 1998; Resh, 1999). whether they could modify PSD-95. We found that four
Protein palmitoylation represents a common lipid mammalian DHHC proteins can palmitoylate PSD-95 in
modification of neuronal proteins (El-Husseini Ael and culturedcells. TheDHHCproteins showsubstrate speci-
Bredt, 2002). This posttranslational change involves ad- ficity, as distinct DHHC isoforms preferentially palmitoy-
dition of the saturated 16 carbon palmitate lipid in a late different neuronal proteins. Palmitoylation appears
thioester linkage to specific cysteine residues. Palmitoy- to be direct, as the DHHC proteins can function alone
lation modifies numerous important neuronal proteins, in vitro. Blocking specific palmitoyl transferases reduces
including the growth-associated protein GAP-43 (Skene palmitoylation and synaptic clustering of PSD-95 and
and Virag, 1989), G protein  subunits (Degtyarev et al., blunts AMPA receptor-mediated synaptic transmission.
1993; Linder et al., 1993;Wedegaertner et al., 1993), non- By palmitoylating PSD-95, specific DHHC proteins con-
receptor tyrosine kinases (Robbins et al., 1995; Shenoy- trol the trafficking of PSD-95 and AMPA receptors, indi-
cating that these enzymes play fundamental roles in
controlling synaptic function.*Correspondence: bredt@itsa.ucsf.edu
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Figure 1. Screening for PSD-95 Palmitoylating Enzymes
(A and B) Individual DHHC clones were transfected together with PSD-95-GFP into COS7 cells (A) and HEK293 cells (B). After metabolic
labeling with [3H]palmitate, proteins were separated by SDS-PAGE, followed by fluorography (upper panel; [3H]Palm) and Coomassie brilliant
blue staining (lower panel; CBB). Arrows indicate the position of PSD-95-GFP. Enhancement of PSD-95 palmitoylation above control (fold) is
indicated beneath each lane. Note that several different DHHC proteins increased incorporation of [3H]palmitate into PSD-95. Mutation of
cysteines 3 and 5 of PSD-95 (C3,5S) abolished its palmitoylation. Mutating DH residues in DHHC clones 7 or 15 to AA (AA7, AA15) blocked
PSD-95 palmitoylation. Treatment with 200 mM DTT (C) or with 1 M hydroxylamine (NH2OH) (D) released DHHC-15-mediated [3H]palmitate
incorporated into PSD-95 (upper panels). The mobility of palmitoylated PSD-95 by DHHC-15 (indicated by asterisks) is shifted (lower panels).
Treatment with DTT or hydroxylamine shifted the mobility of PSD-95 in the presence of DHHC-15 to that of the nonpalmitoylated protein. (E)
Treating cells with 2-bromopalmitate (2-Br) blocked the palmitoylation of PSD-95 induced by DHHC-15. (F) Palmitoylation of PSD-95 induces
a small shift in migration of PSD-95 as detected by CBB staining. Note that PSD-95 cotransfected with DHHC-2, -3, -7, and -15 but not
DHHC-1, -10, -6, or -14 showed mobility shifts (indicated by asterisks).
Results was increased to 200% of control levels with clones
2, 3, and 7. Mutation of PSD-95 cysteines 3 and 5 to
serines abolished palmitoylation. We performed a simi-Identification of PSD-95 Palmitoyl
Acyl Transferases lar screen in HEK293 cells and found that several clones
increased palmitate incorporation into PSD-95 (FigureWe searched the GenBank database for mouse cDNA
clones homologous to the DHHC region of GODZ 1B). Again, the greatest effect was seen with clone 15,
which showed about 5.3-fold increase in PSD-95 palmi-(DHHC-3), which was identified as a GluR1-interacting
protein (Uemura et al., 2002). We isolated and sequenced toylation. Palmitoylation induced by the DHHC proteins
in HEK293 cells also required cysteines 3 and 5 of PSD-products from 23 independent mouse genes that en-
code DHHC proteins (Supplemental Figure S1 [http:// 95. Furthermore, the DHHC motifs were critical, as mu-
tating these residues to alanine in clones 7 or 15 blockedwww.neuron.org/cgi/content/full/44/6/987/DC1/]). We in-
dividually transfected these DNAs together with PSD- their effects on PSD-95 palmitoylation.
Protein palmitoylation involves acylation of a cysteine95 into COS7 cells (60% cotransfection) and assessed
palmitoylation of PSD-95 by metabolic labeling with to form a labile thioester bond, which is sensitive to
reducing agents such as dithiothreitol (DTT) and hydrox-[3H]palmitate (Figure 1A). These experiments showed
that several different DHHC proteins increased incorpo- ylamine (Bizzozero, 1995; Gonzalo and Linder, 1998).
Indeed, we found that the [3H]palmitate incorporatedration of [3H]palmitate into PSD-95. The greatest in-
crease was seen with clone 15, which enhanced PSD- into PSD-95 induced by DHHC clone 15 was released
by treatmentwith 200mMDTT (Figure 1C) or 1Mhydrox-95 palmitoylation nearly 4-fold. PSD-95 palmitoylation
PSD-95 Palmitoyl Transferases
989
Figure 2. Substrate Specificity of the DHHC Family
(A) The phylogenetic tree shows relative relatedness of P-PATs and other DHHC proteins. (B) Increasing amounts of cotransfected DHHC-15
plasmid palmitoylates PSD-95 (1 g plasmid) in a dose-dependent manner. Note that DHHC-15 became autopalmitoylated. (C and D) Substrate
specificity of DHHC proteins. DHHC clones were transfected together with indicated substrates into HEK293 cells, and palmitoylation was
analyzed as in Figure 1. Similar expression level of each substrate was confirmed by immunoblotting (data not shown). The control lane (C)
represents PSD-95 (C3, 5S)-GFP; empty vector for GAP-43, Lck, and Gs; SNAP-25b (C), and GFP-H-Ras (C181, 184S).
ylamine (Figure 1D). Previous studies showed that induce PSD-95 palmitoylation, we named this group the
PSD-95 palmitoyl acyl transferases (P-PATs). The trans-2-bromopalmitate blocked palmitoylation of PSD-95 in
neurons (El-Husseini Ael et al., 2002), and we found that ferase activity appears to be potent and catalytic. That
is, DHHC-15 induced PSD-95 palmitoylation even at a2-bromopalmitate prevented the palmitoylation of PSD-
95 induced by clone 15 (Figure 1E). 1:100 transfection ratio (Figure 2B). When DHHC-15 was
transfected at high levels, it also became palmitoylatedWe wondered about the stoichiometry of palmitoyla-
tion induced by these DHHC proteins. Because the spe- (Figure 2B).
cific activity of [3H]palmitate in cellular metabolic label-
ing studies is unknown, we could not use this approach
to determine the stoichiometry of PSD-95 palmitoyla- Substrate Specificity for P-PATs
Numerous proteins are palmitoylated in neurons andtion.However, palmitoylation can shift a protein’s appar-
ent molecular weight by SDS-PAGE, and we noted that other cells (El-Husseini Ael and Bredt, 2002; Smotrys
and Linder, 2004), and we wondered whether DHHCthis shift occurred for the migration of palmitoylated
PSD-95 (Figure 1F). That is, we saw a quantitative shift proteins show substrate specificity. We therefore co-
transfected the P-PAT cDNAswith other neuronal palmi-in the mobility of PSD-95 in cells cotransfected with
clones 15, 3, and 7. This shift in the mobility of PSD-95 toylated proteins, including GAP-43 (Skene and Virag,
1989), Lck (Shenoy-Scaria et al., 1994), SNAP-25b (Hessindicates that the protein is quantitatively palmitoylated
at at least one, and perhaps both, of the critical cyste- et al., 1992; Lane and Liu, 1997; Vogel and Roche, 1999),
G protein  subunits (Degtyarev et al., 1993; Linder et al.,ines. We saw a partial shift with clone 2; on the other
hand, we saw no shift in the mobility of PSD-95 when 1993;Wedegaertner et al., 1993), andH-Ras (Hancock et
al., 1989). We found that DHHC clones showed similarcotransfected with clones 1, 10, 6, or 14 (Figure 1F). We
also found that treatment of palmitoylated PSD-95 by specificity for palmitoylation of GAP-43 and PSD-95
(Figure 2C). On the other hand, Lck was not palmitoy-DHHC-15 with 200 mMDTT (Figure 1C) or 1 M hydroxyl-
amine (Figure 1D) shifted it to the position of the nonpal- lated byP-PATs (DHHC-7 and -15), but ratherwas palmi-
toylated by DHHC clones 17 and 18 (Figure 2C). Wemitoylated PSD-95, indicating that the mobility shift of
PSD-95 is due only to palmitoylation. found that two P-PATs (DHHC-3 and -7) palmitoylated
SNAP-25b as did a non-P-PAT (DHHC-17). Gs showedWe noted that the DHHC proteins (encoded by clones
2, 15, 7, and 3) that consistently enhanced PSD-95 pal- preference for DHHC-3 and -7. Finally, Ras showed en-
hanced palmitoylation by DHHC-18, which was other-mitoylation in HEK293 and COS7 cells group together
on the DHHC phylogenetic tree (Figure 2A). Although wise active only toward Lck (Figure 2D). Thus, DHHC-3
and -7 have broad substrate specificity, whereasDHHC clones 20 and 23 are closely related, they are
variable in their activity toward PSD-95 (Figures 1A and DHHC-2 and -15 are specific for PSD-95 and GAP-43.
We found similar results using COS7 or L cells (data not1B). Because four clones (2, 15, 3, and 7) quantitatively
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Figure 3. Purified P-PATs Palmitoylate PSD-95 In Vitro
(A) Coomassie staining demonstrates purity of immunoisolated Flag-DHHC-15 and PSD-95-GFP. (B) In vitro palmitoylation. Reactions contained
the isolated proteins and [3H]palmitoyl-CoA. Wild-type DHHC-15 palmitoylated wild-type PSD-95 but not PSD-95-C3,5S (C/S). Note that wild-
type—but not the DH to AA mutant (AA)—became autopalmitoylated. (C) DHHC-2 but not DHHC-18 palmitoylated PSD-95. (D) DHHC-15-
mediated palmitoylation of PSD-95 was blocked in the presence of 2-bromopalmitate (2-Br palm). (E) Fatty acyl-CoA specificity of the DHHC-
15. Unlabeled acyl-CoA (2.5 M each) were added with 0.5 M [3H]palmitoyl-CoA; lauroyl-CoA (C12), myristoyl-CoA (C14), palmitoyl-CoA
(C16), and stearoyl-CoA (C18). Results are expressed as the fraction of PAT activity in the absence of competitor. (F and G) Mutagenesis of
DHHC-15 showed that the DHHC core and the C terminus were required for PAT activity. Note that DHHC-15 autopalmitoylation correlated
with PSD-95 PAT activity. The signature DHHC motif and transmembrane domains are indicated by red and green boxes, respectively.
shown). Taken together, these experiments show that The lipid substrate specificity of DHHC-15 was exam-
ined by adding unlabeled acyl-CoA competitors (at 2.5DHHC proteins show exquisite substrate specificity.
M, a 5-fold excess) to the radioactive in vitro PAT
reaction. Addition of myristoyl-CoA (C14) and palmitoyl-Characterization of P-PAT Activity
Wenext askedwhether a purified P-PAT could palmitoy- CoA (C16) resulted in80% inhibition (Figure 3E). Lauroyl-
CoA (C12) and stearoyl-CoA (C18) were less effective atlate purified PSD-95. To address this, we immunoiso-
lated DHHC-15 and PSD-95-GFP. These isolated pro- similar concentrations (35% and 55% inhibition, re-
spectively). This lack of strict acyl-CoA substrate speci-teins were homogenous, as determined by Coomassie
staining following SDS-PAGE (Figure 3A). Incubation of ficity for P-PAT correlates with the heterogeneity of thio-
ester-linked fatty acids on proteins in vivo (Smotrys andthese purified proteins together with [3H]palmitoyl-CoA
showed incorporation of radiolabel into PSD-95 (Figure Linder, 2004).
To identify the critical domains for P-PAT activity,3B). This labeling required the critical cysteines at resi-
dues 3 and 5 of PSD-95 as well as the conserved DHHC mutants of DHHC-15 were constructed and transfected
into HEK293 cells, and palmitoylation of PSD-95 wasresidues of clone 15. Interestingly, only active DHHC-15
autopalmitoylated. As a control, we found that DHHC assessed by [3H]palmitate metabolic labeling (Figures
3F and 3G). DHHC-15 (wt) and -N (aa 19–337) enhancedclone 18, which showed autopalmitoylation activity, was
inactive toward PSD-95, whereas DHHC-2, another PSD-95 palmitoylation. We found that AAHC-15, DHHC-
15-C (aa 1–238), (aa 86–201) and -C (aa 239–337) didP-PAT, palmitoylated purified PSD-95 (Figure 3C). This
in vitro palmitoyl transferase activity was also blocked not enhance PSD-95 palmitoylation. Another mutant in
the core domain (DHHC-15-C159S) also failed to en-by 2-bromopalmitate (Figure 3D).
PSD-95 Palmitoyl Transferases
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Figure 4. Effect of DHHC Protein on PSD-95 Distribution in HEK293 Cells
(A) Indicated GFP-tagged cDNAs (PSD-95, H-Ras, and SNAP-25b) were cotransfected with HA-tagged DHHC clones into HEK293 cells. The
cells were stained by anti-HA antibody (red). The GFP fluorescence intensity (green) on the white lines (25 m) was calculated by the LSM510
software and quantitated graphically. DHHC-15 specifically increased the segregation of wild-type PSD-95—but not H-Ras—to the perinuclear
region. Mutating the DH residues to AA (AAHC-15) blocked the effect of DHHC-15 on PSD-95 trafficking. Cotransfection of DHHC-7 with
SNAP-25b caused redistribution of SNAP-25b to a perinuclear domain. (B) DHHC-15 redistributes PSD-95 from Triton X-100-soluble to
-insoluble fractions. Triton X-100-soluble (S) and -insoluble (I) fractions from transfected HEK293 cells were separated and probed for PSD-
95 and tubulin.
hance PSD-95 palmitoylation, consistent with the previ- PSD-95 as reported for GODZ (DHHC-3) and GABA-A
receptor 2 subunit (Keller et al., 2004).ous report in yeast Akr1p (Roth et al., 2002) (Figures 3F
and 3G). The PAT activity of DHHC-15 correlated with Our previous work showed that palmitoylation regu-
lates the association of PSD-95with cellularmembranesits autopalmitoylation (Figures 3F and 3G).
(El-Husseini Ael et al., 2002; Topinka and Bredt, 1998).
In transfected HEK293 cells, PSD-95 fractionates with
P-PAT Activity Targets PSD-95 both the TritonX-100-soluble and Triton X-100-insoluble
to Cellular Membranes (membrane-associated) fractions. This heterogeneous
We next asked whether P-PATs could modulate the fractionation held true for both wild-type PSD-95 as well
function of PSD-95 in vivo. Previous studies showed as the mutant lacking the critical cysteines at positions
that palmitoylation targets PSD-95 to a perinuclear do- 3 and 5. Cotransfection with clone 15 caused redistribu-
main (El-Husseini et al., 2000a). Fitting with this, we tion of wild-type PSD-95 to the membrane-associated
found that cotransfection with clone 15 increased the fraction (Figure 4B). This effect was specific, as clone
segregation of PSD-95 to this perinuclear region (Figure 15 did not alter the fractionation of tubulin.
4A). This redistribution required the critical cysteines of
PSD-95 and also the DHHC region of clone 15. This
effect was specific, as clone 15 did not alter the distribu- P-PATs Regulate PSD-95 Function in Neurons
Next, we asked if P-PATs are expressed in brain. Previ-tion of H-Ras (Figure 4A). Furthermore, DHHC-7, which
palmitoylates SNAP-25b (Figure 2D), increased the tar- ous reports showed that DHHC-2 (ream) (Oyama et al.,
2000) and DHHC-3 (GODZ) (Uemura et al., 2002) aregeting of SNAP-25b to the perinuclear region. This redis-
tribution required the critical cysteines of SNAP-25b expressed ubiquitously in brain and peripheral tissues.
Our Northern blotting experiments showed that the 3.1(data not shown). We found that this redistribution of
PSD-95 and SNAP-25b was likely not due to their physi- kb DHHC-7 mRNA was also widely expressed in brain
and peripheral tissues; by contrast, the 5.8 kb DHHC-cal interaction with DHHC proteins, because we could
not detect stable association by immunoprecipitation 15 mRNA was expressed mainly, but not exclusively, in
brain (Figure 5A). We found that DHHC-18 mRNA, which(data not shown). However, we cannot neglect the possi-
bility that direct binding contributes to redistribution of has PAT activity for H-Ras, was expressed ubiquitously
Neuron
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X-100-insoluble fractions (Figure 7A). In contrast, inhibi-
tion of P-PAT activity by GFP-C159S increased the
amount of soluble PSD-95 (Figure 7A). Under these con-
ditions, the subcellular distribution of other palmitoy-
lated proteins, Gs and Lck, did not change. Expression
of the dominant-negative C159S mutant significantly in-
hibited PSD-95 synaptic clustering, whereas wild-type
DHHC-15did not (Figure 7B). BecausePSD-95palmitoy-
lation controls AMPA receptor function (El-Husseini et
al., 2000b; El-Husseini Ael et al., 2002), we examined
clustering of AMPA receptor subunit GluR2. Expression
of C159S significantly reduced surface clustering of
GluR2, whereas wild-type DHHC did not (Figure 7B).
Under the conditions, the clustering of synaptophysin
(Figure 7B) and the NR1 subunit of NMDA receptors
(data not shown) did not change. Finally, we asked
whether inhibition of P-PAT activity by C159S changed
glutamatergic transmission. AMPA receptor-mediated
miniature excitatory postsynaptic currents (mEPSCs)
were monitored with whole-cell recordings from cul-
tured hippocampal neurons. We found a significant
reduction in the amplitude of synaptic events in C159S-
infected neurons (Figure 7Cb), but not in DHHC-15-
infected cells (Figure 7Ca).Figure 5. P-PATs Are Expressed in Brain
Northern blot analysis used mRNA (2 g) (A) or total RNA (20 g)
(B and C) isolated from different mouse tissues (A and B) and brain Discussion
regions (C). Br, brain; Sp, spleen; Lu, lung; Li, liver; Sk, skeletal
muscle; Ki, kidney; Te, testis; He, heart; Cx, cortex; Cb, cerebellum; This study identifies a family of four P-PAT enzymes
Hi, hippocampus; St, striatum. that are expressed in brain and can mediate palmitoyl
transfer to PSD-95. These enzymes share a conserved
and critical DHHCmotif, which has been found in palmi-and DHHC-20, closely related to DHHC-2 and 15, oc-
curred mainly in lung (Figure 5B). DHHC-23, closely re- toyl transferases in yeast (Lobo et al., 2002; Roth et al.,
2002). The enzymes can function alone in vitro and showlated to DHHC-3 and -7, was largely restricted to brain
(Figure 5B). DHHC-17 (HIP14), which has PAT activity specificity for neuronal substrate proteins. Furthermore,
P-PATs regulated AMPA receptor-mediated synapticfor SNAP-25b, was expressed widely (Singaraja et al.,
2002). All four P-PATs were expressed in all brain re- function through PSD-95 palmitoylation.
Understanding the catalytic mechanism for P-PATsgions, including cerebral cortex, cerebellum, hippocam-
pus, and striatum (Figure 5C). represents an important future goal. The thioester bond
in the substrate palmitoyl-CoA is of high energy and isTo determine whether P-PATs palmitoylate endoge-
nousPSD-95, we sought to identify a dominant-negative similar to that in the palmitoylated protein product. This
indicates that an energy source is not necessary forP-PAT construct. When cotransfected with wild-type
DHHC-15, the AAHC-15 or C159S mutant blocked PSD- this reaction. Indeed, we find that a purified P-PAT can
directly modify purified PSD-95. It is interesting to note95 palmitoylation (Figure 6A). C159S mutant also blocked
DHHC-2-induced, but not DHHC-3- or -7-induced, PSD- that P-PATs, as well as the other DHHC proteins (Lobo
et al., 2002; Roth et al., 2002), autoacylate in the pres-95 palmitoylation. Furthermore, C159S did not affect
DHHC-3-induced GAP-43 palmitoylation or DHHC-3- ence of palmitoyl-CoA, and this requires the signature
DHHC domain. This may indicate that a thioester inter-induced Gs palmitoylation (Supplemental Figure S2
[http://www.neuron.org/cgi/content/full/44/6/987/ mediate on the DHHC protein underlies the reaction
mechanism.DC1/]). Under these conditions, other mutants with no
PAT activity, such as DHHC-15-C and DHHC-15-C, Mechanisms that control the activity of P-PATs remain
uncertain. Previous work shows that palmitate turnoverfailed to inhibit PAT activity of DHHC-15 (data not
shown). Consistent with these data, C159S inhibited on proteins can be dynamically regulated by physiologi-
cal stimuli. Palmitate turnover on G subunits is rapidlyDHHC-15-induced, but not DHHC-3-induced, PSD-95
redistribution to perinuclear regions (Figure 6B). increased by activation of their associated G protein-
coupled receptors (Wedegaertner and Bourne, 1994).We used these tools to study endogenous PSD-95
palmitoylation in neurons. Metabolic labeling experi- Furthermore, palmitate cycling on PSD-95 is augmented
by calcium influx through NMDA receptors, which arements showed that GFP-DHHC-15 quadrupled PSD-95
palmitoylation (Figure 6C), whereas GFP-C159S inhib- also linked to PSD-95 (El-Husseini Ael et al., 2002). In
yeast, the DHHC protein Akr1p palmitoylates casein ki-ited neuronal PSD-95 palmitoylation (57.6%  4.0% of
control cells, n  4, *p  0.001) (Figure 6C). Next, we nase, and this activity is increased by ATP in vitro (Roth
et al., 2002). It will be critical to determinewhether nucle-askedwhether P-PATs control PSD-95 synaptic cluster-
ing and function. Overexpression of GFP-DHHC-15 in otides or other second messengers might control the
activity of P-PATs in neurons. In our previous paper (El-neurons increased the amount of PSD-95 in Triton
PSD-95 Palmitoyl Transferases
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Figure 6. P-PATs Participate in PSD-95 Pal-
mitoylation in Neurons
(A) Mock vector (indicated by “	”), AAHC-15
(AA), or C159S mutant (see Figure 3F) were
cotransfected with DHHC clones 15, 2, 3, or
7 together with PSD-95 into HEK293 cells.
After metabolic labeling with [3H]palmitate,
proteins were separated by SDS-PAGE, visu-
alized by fluorography (upper panel; [3H]Palm)
and immunoblotted with anti-PSD-95 (lower
panel). C159S (and to a lesser extent AA) in-
hibited DHHC-15- or -2-induced, but not
DHHC-3- or -7-induced, PSD-95 palmitoyla-
tion. (B) C159S together with DHHC-15 or
DHHC-3 were cotransfected with PSD-95-
GFP into HEK293 cells. C159S blocked
DHHC-15- but not DHHC-3-induced PSD-95
redistribution to perinuclear regions. Scale
bar, 10 m. (C) Cultured hippocampal neu-
rons were infected with Semliki forest viruses
expressing GFP, GFP-DHHC-15 wild-type
(wt), or GFP-C159S. The neurons were treated
with 3 mCi/ml [3H]palmitate for 4 hr. Immuno-
precipitated PSD-95 was resolved by SDS-
PAGE, followed by fluorography ([3H]Palm) and
Coomassie staining (CBB). Wild-type DHHC-
15 enhanced whereas the C159S mutant in-
hibited palmitoylation of PSD-95.
Husseini Ael et al., 2002), we suggested that unidentified substrates suggests that therapeutically useful antago-
nists may exist with defined sites of action. It will bepalmitoyl thioesterase enzymes control activity-stimu-
lated palmitate turnover on PSD-95. Whether P-PAT ac- important to develop these isoform-specific modulators
of P-PATs and other DHHC enzymes to determine thetivity might also be regulated by neuronal activity will
require future studies. physiological and pathological roles for these enzymes
throughout the body.Members of the large family of 23 mammalian DHHC
proteins have a conserved region that includes the cata-
Experimental Procedureslytically critical DHHC domain. However, the C-terminal
and N-terminal regions of these proteins are divergent
Cloning and Plasmid Constructions
and some contain regulatory regions such as SH3 do- cDNAs encoding mouse DHHC proteins and mouse H-Ras were
mains or ankyrin repeats. This is akin to protein kinases, cloned by RT-PCR using mouse brain total RNA or amplified from
which also share a core catalytic region and differ in isolated EST clones (for clone 10, 13, and 19) and primers (see
Supplemental Figure S1 [http://www.neuron.org/cgi/content/full/regulatory domains that afford for differential control.
44/6/987/DC1/]). All PCR products were analyzed by DNA sequenc-It is interesting that the P-PATs occur on one limb of
ing. The cDNAs were subcloned into pEF-Bos-HA, pEGFP-C1 (BDthe DHHC phylogenetic tree (Figure 2A), and this may
Biosciences), pCAGGS-FLAG, and pSCA1 (Stein et al., 2003). To
reflect a structural correlate to enzyme specificity for obtain DHHC-15-C (aa 1–238), -N (aa 19–337), (aa 86–201), and
PSD-95 palmitoylation. The cysteines of palmitoylated -C (aa 239–337), the corresponding fragments were subcloned into
PSD-95 occur near the N terminus; however, a diversity pEF-Bos-HA. The mutants AA-7, AA-15, and C159S were generated
using a site-directed mutagenesis by changing DH (aa 157 and 158;of other sequences in other proteins can be palmitoy-
DHHC-7) to AA, DH (aa 156 and 157; DHHC-15) to AA, and C (aalated. Transmembrane proteins often are palmitoylated
159; DHHC-15) to S, respectively. EGFP-C1-H-Ras (C181, 184S) wasat juxtamembrane locations. Palmitoylation can also oc-
also generated with a site-directed mutagenesis. pGW1-PSD-95,
cur in the context of other lipid modifications (El-Hus- PSD-95 (C3, 5S), and GAP-43 fused to GFP were described pre-
seini Ael and Bredt, 2002; Smotrys and Linder, 2004). viously (El-Husseini et al., 2000a). pcDNA3-SNAP-25b and pcDNA3-
Ras protein is palmitoylated at a C-terminal site that is SNAP-25b (C), whose palmitoylated cysteines were deleted, were
provided by Dr. Paul A. Roche (National Institutes of Health, MD)adjacent to a site for prenylation; Gi subunit is palmitoy-
(Vogel and Roche, 1999). pcDNA3-HA-Gs was a gift of Dr. Philiplated at an N-terminal cysteine that is adjacent to sites
B. Wedegaertner (Thomas Jefferson University, PA) (Evanko et al.,for myristoylation. In light of the results here, we suspect
2000). The Lck cDNA was provided by Dr. Art Weiss (UCSF) and
that other limbs of the DHHCphylogenetic treewill show was subcloned into pcDNA3.1.
specificity for these other classes of palmitoylated pro-
teins. In Vivo Palmitate Labeling
Transfected HEK293 or COS7 cells were preincubated for 30 minThe family of DHHC palmitoyl transferases represent
in serum-free DMEM with fatty acid-free bovine serum albumin (10intriguing drug targets. The transforming activity of on-
mg/ml; Sigma). Cells were then labeled with 0.5 mCi/ml [3H]palmiticcogenes require their palmitoylation (Hancock et al.,
acid (PerkinElmer) for 4 hr in the preincubation medium. Cells were1989). In the nervous system, numerous synaptic pro-
washed with PBS, scraped with SDS-PAGE sample buffer (62.5 mM
teins, including serotonin receptors and synaptic vesicle Tris-HCl [pH 6.8], 10% glycerol, 2% SDS, and 0.001% bromophenol
proteins, are palmitoylated (El-Husseini Ael and Bredt, blue) with 10 mM DTT and boiled for 2 min. For DTT treatment,
radiolabeled proteins were dissolved in SDS sample buffer with 2002002). The specificity of the DHHC enzymes for protein
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Figure 7. Inhibition of P-PATs Perturbs PSD-95 Function in Neurons
(A) Cultured hippocampal neurons infected with Semliki forest virus expressing GFP (indicated as “	”), GFP-DHHC-15 (wt), or GFP-C159S
were harvested, and the lysates were fractionated. Triton X-100-soluble (S) and -insoluble (I) fractions were separated and probed for PSD-
95, Gs, and Lck. (B) Cultured hippocampal neurons were infected with Semliki forest virus expressing GFP-DHHC-15 (wt) or GFP-C159S. At
24 hr after infection, PSD-95 and surface GluR2 were stained (red). Infected neurons are indicated by arrowheads. Higher-magnification
micrographs of the boxed regions are shown in the panels below. Synaptophysin (blue) and GluR2 (red) were doubly stained. Quantitative
analysis shows that C159S reduced synaptic PSD-95 and surface GluR2 clustering (*p  0.001). Scale bar, 10 m. (C) Overexpression of
GFP-C159S (b) (n 6), but not DHHC-15 (a) (n 7), significantly (Student’s t test) reduced the amplitude of AMPA receptor-mediated mEPSCs.
mM DTT and boiled for 5 min (Bizzozero, 1995). For Gs palmitate 1%TritonX-100. ImmunoprecipitatedPSD-95was resolvedby SDS-
PAGE, followed by fluorography and Coomassie staining.labeling, the cells were treated with 10% (w/v) trichloroacetic acid.
The resulting precipitates were suspended in SDS sample buffer
with 10 mM DTT. For fluorography, protein samples were separated Preparation of Recombinant Proteins
FLAG-tagged DHHC clones were purified from transfected HEK293by SDS-PAGE. Gels were treated with Amplify (Amersham) for 30
min, dried under vacuum, and exposed to (Kodak Biomax MS) cells seeded onto a 10 cm dish (5
 106 cells). At 24 hr after transfec-
tion, cells were lysed with lysis buffer B (20 mM Tris-HCl [pH 7.4],at	80C. After autoradiography, the bands were scanned and ana-
lyzed with NIH software. To quantitate the relative PAT activity of 1 mM EDTA, 100 mM NaCl, 1% Triton X-100, 10 g/ml leupeptin).
The lysates were mixed with 25 l anti-FLAG M2 mAb-Agaroseeach DHHC clone, we quantitated the ratio of palmitoylated PSD-
95 to total PSD-95 (measured by Coomassie staining). For hydroxyl- (Sigma) for 2 hr at 4C. After washing the beads with buffer C (20
mM Tris-HCl [pH 7.4], 1 mM EDTA, 50 mM NaCl, 0.1% Triton X-100,amine treatment, radiolabeled cells were sonicated in phosphate
buffer and suspended with 1 M hydroxylamine (NH2OH) (pH 7.0) or 10 g/ml leupeptin), the bound proteins were eluted by addition of
buffer D (20 mM Tris-HCl [pH7.4], 0.05% Triton X-100, 250 g/ml1M Tris-HCl (pH 7.0). For 2-bromopalmitate treatment, HEK293 cells
were labeled with [3H]palmitic acid in the presence of 2-bromopal- FLAG peptide). PSD-95-GFP was immunoprecipitated by anti-GFP
antibody from transfected HEK293 cells. After washing the beadsmitate.
Cultured hippocampal neurons (5 
 105 cells/well) (DIV 16–21) with buffer C, the beads were taken up in buffer E (20 mM Tris-HCl
[pH7.4], 0.05% Triton X-100).were infected with GFP-DHHC-15 wild-type or C159S expressing
Semliki forest virus (Stein et al., 2003). At 20 hr after infection, the
cells were labeled for 4 hr in neurobasal media containing 3 mCi/ In Vitro PAT Assay
[3H]palmitoyl-CoA was synthesized from [3H]palmitic acid and CoAml [3H]palmitic acid. Labeled cells werewashedwith PBS and resus-
pended in 0.15 ml lysis buffer A (20 mM Tris-HCl [pH 7.4], 1 mM using acyl-CoA synthetase (Sigma) and purified as described (Taylor
et al., 1990). The PAT assay was performed as described (Lobo etEDTA, 100 mMNaCl, and 1% SDS). After 5 min extraction, 1% Triton
X-100 was added to a final volume of 1.5 ml. After centrifugation at al., 2002; Roth et al., 2002). Briefly, FLAG-DHHC (50 nM) was added
to PSD-95-GFP beads (100 nM) in 50 mMMES (pH 6.4). The reaction20,000 
 g for 10 min, the supernatants were incubated with rabbit
anti-PSD-95 antibody (El-Husseini Ael et al., 2002) for 1 hr and then was started by the addition of 0.5 M [3H]palmitoyl-CoA (0.5 Ci),
incubated for 1 hr at 30C and stopped by the addition of a 2
 SDSincubated for 1 hr with 30 l protein A Sepharose (Pharmacia) at
4C. Immunoprecipitates were washed three times with buffer con- sample buffer with 20 mM DTT. Reaction proteins were resolved by
SDS-PAGE, followed by fluorography and silver staining.taining 20 mM Tris-HCl (pH 7.4), 1 mM EDTA, 100 mM NaCl, and
PSD-95 Palmitoyl Transferases
995
Immunofluorescence Analysis HEPES, 0.2 mM EGTA, 8 mM NaCl, 10 mM TEA-Cl, 4 mM Mg-ATP,
0.3 mM Mg-GTP, 5 mM QX-314, and 0.1 mM spermine (pH 7.2).HEK293 cells were seeded onto three 12 mm cover slips in each
well of a 6-well cell culture plate (3 
 105 cells/well). At 24 hr after mEPSCs (about 100 events per cell) were automatically detected
using in-house software. Picrotoxin and TTX were from Sigma.transfection, the cells were fixed with 4%paraformaldehyde at room
temperature for 10 min, permeabilized with 0.1% Triton X-100 for
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